Annual surveillance of antimicrobial resistant pathogens from pediatric acute rhinosinusistis: 2009–2013

Abstract

  In order to select precisely the right antibacterial drug for treatment of pediatric acute rhinosinusitis, we must constantly monitor the frequency with which drug-resistant bacteria are detected. Bacterial tests of purulent nasal mucus were performed for ?? pediatric acute rhinosinusitis patients examined at my hospital between January 2012 and December 2013, and bacteriological examinations were then performed for the 1347 patients from whom Streptcoccus pneumoniae or Haemophilus influenzae was detected to compare the results with those of the 2009–2010 survey. As a result, drug-resistant S. pneumoniae (DRSP) showed significant decreases in 2012 and 2013 compared to the 2009–2010 survey, although no such difference was observed for ampicillin-resistant H. influenzae. It will be necessary to continue monitoring the detection frequency of DRSP.